159938 医药
已收盘 06-10 15:00:00
资讯
新帖
简况
医药板块逆势走强,基本面有望持续改善,关注港股通创新药ETF易方达(159316)配置价值
证券之星 · 13分钟前
医药板块逆势走强,基本面有望持续改善,关注港股通创新药ETF易方达(159316)配置价值
拓新药业:新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务
证券之星 · 15:00
拓新药业:新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务
港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议
智通财经 · 13:39
港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议
港股异动 | 生物医药股逆市活跃,华昊中天医药-B暴涨逾40%
老虎资讯综合 · 11:36
港股异动 | 生物医药股逆市活跃,华昊中天医药-B暴涨逾40%
长春高新:公司全力聚焦医药创新与主业发展
证券之星 · 08:57
长春高新:公司全力聚焦医药创新与主业发展
港股收评:恒指跌,恒科涨;CPO概念爆发,半导体板块全天活跃,军工上涨;医药、石油石化、煤炭下跌;智谱大跌超13%,中国石油尾盘跌超4%
中新经纬 · 06-09 16:12
港股收评:恒指跌,恒科涨;CPO概念爆发,半导体板块全天活跃,军工上涨;医药、石油石化、煤炭下跌;智谱大跌超13%,中国石油尾盘跌超4%
6月8日海创药业跌7.50%,鹏华医药科技股票A基金重仓该股
证券之星 · 06-08 16:43
6月8日海创药业跌7.50%,鹏华医药科技股票A基金重仓该股
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
金吾财讯 · 06-08 13:43
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
上药益药医药(上海)有限公司成立
证券日报 · 06-08 13:36
上药益药医药(上海)有限公司成立
大型医药股表现活跃,指数逆势收涨,医药ETF易方达(512010)本周“吸金”超8亿元
证券之星 · 06-05
大型医药股表现活跃,指数逆势收涨,医药ETF易方达(512010)本周“吸金”超8亿元
6月5日悦康药业跌15.77%,富国医药创新股票A基金重仓该股
证券之星 · 06-05
6月5日悦康药业跌15.77%,富国医药创新股票A基金重仓该股
创胜集团医药-B(06628)建议委任徐汉森为非执行董事
智通财经 · 06-04
创胜集团医药-B(06628)建议委任徐汉森为非执行董事
差异化创新破局,科望医药领航免疫治疗新蓝海
格隆汇 · 06-04
差异化创新破局,科望医药领航免疫治疗新蓝海
楚天科技:将楚天打造成世界医药领军企业之一
证券之星 · 06-04
楚天科技:将楚天打造成世界医药领军企业之一
长春高新:公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景
证券之星 · 06-04
长春高新:公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景
国产双靶点GLP-1迎新进展,翰森制药减重新药申报获受理|医药早参
每日经济新闻 · 06-04
国产双靶点GLP-1迎新进展,翰森制药减重新药申报获受理|医药早参
和誉-B(02256):和誉医药于PAGE会议展示ABSK-011(依帕戈替尼)在HCC患者中的联合建模新框架
智通财经 · 06-04
和誉-B(02256):和誉医药于PAGE会议展示ABSK-011(依帕戈替尼)在HCC患者中的联合建模新框架
宏辉果蔬推进业务结构升级,7亿元控股施美药业拓展医药赛道
长三角资本局 · 06-03
宏辉果蔬推进业务结构升级,7亿元控股施美药业拓展医药赛道
星昊医药(920017)披露2025年年度权益分派实施公告,6月3日股价下跌0.06%
证券之星 · 06-03
星昊医药(920017)披露2025年年度权益分派实施公告,6月3日股价下跌0.06%
欧康医药(920230)披露回购股份注销完成暨股份变动公告,6月3日股价下跌0.93%
证券之星 · 06-03
欧康医药(920230)披露回购股份注销完成暨股份变动公告,6月3日股价下跌0.93%
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"医药","latestPrice":0.567,"timestamp":1781074980000,"preClose":0.562,"halted":0,"volume":69686800,"delay":0,"changeRate":0.0089,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":0.005,"latestTime":"06-10 15:00:00","open":0.561,"high":0.569,"low":0.558,"amount":39289200,"amplitude":0.0196,"askPrice":0.568,"askSize":15192,"bidPrice":0.567,"bidSize":7935,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781141400000},"marketStatusCode":5,"adr":0,"adjPreClose":0.562,"symbolType":"fund","openAndCloseTimeList":[[1781055000000,1781062200000],[1781067600000,1781074800000]],"highLimit":0.618,"lowLimit":0.506,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.051906,"marketValue":0,"turnoverRate":0,"status":0,"floatMarketCap":0},"requestUrl":"/m/hq/s/159938","defaultTab":"news","newsList":[{"id":"2642428491","title":"医药板块逆势走强,基本面有望持续改善,关注港股通创新药ETF易方达(159316)配置价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642428491?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:04","pubTimestamp":1781089491,"startTime":"0","endTime":"0","summary":"6月10日,医药板块主要指数逆势上涨,截至收盘,恒生港股通创新药指数上涨2.0%,中证港股通医药卫生综合指数上涨1.5%,中证创新药产业指数上涨1.8%,中证生物科技主题指数上涨1.0%,沪深300医药卫生指数上涨1.6%。从估值维度看,经过这一轮调整,港股创新药板块估值已有所回落,沪深300医药指数也处于近10年历史较低分位。此外,A股创新药板块一季度收入同比增长26.4%,多家生物科技公司已实现扭亏为盈,基本面有望持续改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026061000035676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159316","09939","159938","516080","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642443135","title":"拓新药业:新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2642443135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642443135?lang=zh_cn&edition=full","pubTime":"2026-06-10 15:00","pubTimestamp":1781074851,"startTime":"0","endTime":"0","summary":"证券之星消息,拓新药业06月09日在投资者关系平台上答复投资者关心的问题。公司前次募集资金投资项目均已完成,新乡基地将继续承载公司原料药、医药中间体、功能食品原料产品生产、研发等核心业务。通过优化产能布局,实现新乡与内蒙古两大基地的协同互补,有利于提升整体核心竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000021133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0239","159938","BK1574","09939","301089","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642108254","title":"港股异动 | 先声药业(02096)午后涨超3% 近日与普祺医药就普美昔替尼凝胶订立独家推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2642108254","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642108254?lang=zh_cn&edition=full","pubTime":"2026-06-10 13:39","pubTimestamp":1781069998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,先声药业(02096)午后涨超3%,截至发稿,涨3.03%,报9.87港元,成交额4009.82万港元。消息面上,近日,先声药业发布公告,本集团与北京普祺医药科技股份有限公司(普祺医药)就普美昔替尼凝胶订立独家推广服务协议(该协议)。根据该协议,本集团将获得普美昔替尼凝胶在中国内地、香港及澳门所有皮肤病领域适应症的独家推广权益。目前,普美昔替尼凝胶成人与青少年特应性皮炎(AD)适应症新药上市申请(NDA)已获国家药品监督管理局药品审评中心(CDE)受理。本次合作将进一步强化本集团在自身免疫领域的产品布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","09939","BK1574","02096","VXUS","BK1161","BK1515","BK1583","BK4588","BK4585","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152361325","title":"港股异动 | 生物医药股逆市活跃,华昊中天医药-B暴涨逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152361325","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152361325?lang=zh_cn&edition=full","pubTime":"2026-06-10 11:36","pubTimestamp":1781062600,"startTime":"0","endTime":"0","summary":"6月10日,港股生物医药股逆市活跃,$华昊中天医药-B(02563)$暴涨逾40%,$迈威生物-B(02493)$涨逾23%,$宜明昂科-B(01541)$涨逾8%,$银诺医药-B(02591)$、$泰格医药(03347)$、$科伦博泰生物(06990)$、药明康德跟涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"324431b18d184842b2237adf08e51534","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4588","VXUS","BK1574","09939","BK1161","159938","XBI","BK1515","161726","02563","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642678416","title":"长春高新:公司全力聚焦医药创新与主业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2642678416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642678416?lang=zh_cn&edition=full","pubTime":"2026-06-10 08:57","pubTimestamp":1781053033,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新(000661)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司会尽快剥离房地产业务吗?长春高新回复:您好,感谢您对公司的关注,,公司全力聚焦医药创新与主业发展,同时也正推进辅业轻资产转型;同时,未来地产板块如有其他达到信息披露标准的情况,公司会按照法律法规要求履行披露义务,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000007776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0046","BK1515","BK0188","BK0028","09939","BK0057","BK0075","000661","159938","BK0239","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642468767","title":"港股收评:恒指跌,恒科涨;CPO概念爆发,半导体板块全天活跃,军工上涨;医药、石油石化、煤炭下跌;智谱大跌超13%,中国石油尾盘跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642468767","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642468767?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:12","pubTimestamp":1780992720,"startTime":"0","endTime":"0","summary":"9日,港股主要指数走势分化,恒生科技指数盘中涨超1%。截至收盘,恒指跌0.37%,恒生科技指数涨0.29%。盘面上,硬件设备、半导体、造纸、建材、环保、军工等板块上涨。CPO概念股活跃,长飞光纤光缆盘中涨超10%。石油石化、煤炭、医药、交运、地产等板块跌幅居前;CRO、汽车电子、港口运输等概念走低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606093765131790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XLE","USE","WTIU","SMHX","DBC","IEO","BNO","159938","HSI","DBE","02513","ERX","USL","FTXL","PXE","VGT","OILT","GUSH","SHLD","VXUS","DIG","IXC","OIH","SOXL","TEKX","159019","XES","OILU","CHPY","PXJ","OILK","SMH","09939","161032","SOXY","USD","SOXS","USOI","DRIP","SOXQ","PSI","SOXX","SSG","161024","VDE","CHPS","XOP","FTXN","DRLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641210764","title":"6月8日海创药业跌7.50%,鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641210764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641210764?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:43","pubTimestamp":1780908209,"startTime":"0","endTime":"0","summary":"证券之星消息,6月8日海创药业跌7.50%创60日新低,收盘报34.88元,换手率2.57%,成交量2.55万手,成交额9016.46万元。重仓海创药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","09939","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示,2026年第一季度,海外CXO行业整体呈现分化复苏格局,全球生物制药融资环境出现实质性改善,带动需求逐步回暖,但早期初创企业资金压力仍未完全缓解,不同细分赛道、不同规模企业的表现存在差异,行业结构性分化特征进一步凸显。展望2026年,海外头部CXO企业收入指引仍维持稳健小幅增长格局,叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏,行业景气度延续上行态势,成长确定性进一步增强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","06127","BK1515","BK1191","LU0708995583.HKD","09939","BK1141","HK0000320223.HKD","LU1046422090.SGD","LU0856984785.SGD","HK0000320264.USD","LU2045819591.USD","02359","LU0348735423.USD","LU0417516902.SGD","LU0572944931.SGD","LU0516422952.EUR","01548","LU1720050803.USD","LU0140636845.USD","LU2242644610.SGD","BK1521","LU2039709279.SGD","03347","LU0320764599.SGD","06821","LU0348767384.USD","LU0326950275.SGD","LU0417516738.SGD","LU1880383366.USD","LU0456827905.SGD","159938","LU0307460666.USD","01521","02269","LU3063872942.SGD","LU0588546209.SGD","BK1574","01873","HK0000306685.HKD","LU0516423091.SGD","03759","LU0039217434.USD","LU0516422440.USD","SG9999002463.SGD","LU1688375341.USD","LU0359201612.USD","LU0516422366.SGD","BK1589","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641106434","title":"上药益药医药(上海)有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2641106434","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641106434?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:36","pubTimestamp":1780896960,"startTime":"0","endTime":"0","summary":"企查查APP显示,近日,上药益药医药(上海)有限公司成立,法定代表人为顾斌,注册资本为8亿元,经营范围包含:第一类医疗设备租赁;机械设备租赁;仓储设备租赁服务;数字创意产品展览展示服务等。企查查股权穿透显示,该公司由上海医药(601607)全资子公司上药控股有限公司、上海医药大健康云商股份有限公司共同持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763482714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","09939","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641411787","title":"大型医药股表现活跃,指数逆势收涨,医药ETF易方达(512010)本周“吸金”超8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641411787","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641411787?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:13","pubTimestamp":1780658013,"startTime":"0","endTime":"0","summary":"截至收盘,沪深300医药卫生指数上涨0.8%,中证生物科技主题指数上涨0.1%,中证创新药产业指数下跌0.02%,中证港股通医药卫生综合指数下跌0.8%,恒生港股通创新药指数下跌1.5%。Wind数据显示,医药ETF易方达(512010,联接基金A/C:001344/007883)本周前四个交易日连续获资金净流入,合计超8亿元。中信建投研报表示,医疗器械行业将迎来业绩修复和估值重塑。中国器械企业龙头持续创新、出海、并购,有望成长为全球医疗器械龙头,行业成长逻辑已从国产替代拓展到国际化和技术创新,估值迎来重塑机遇。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026060500035074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1161","BK1515","BK1574","09939","512010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641115053","title":"6月5日悦康药业跌15.77%,富国医药创新股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641115053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641115053?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:38","pubTimestamp":1780648713,"startTime":"0","endTime":"0","summary":"证券之星消息,6月5日悦康药业跌15.77%创60日新低,收盘报13.73元,换手率8.54%,成交量38.41万手,成交额5.46亿元。重仓悦康药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共7家,其中持有数量最多的公募基金为富国基金的富国医药创新股票A。富国医药创新股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1574","BK1161","BK0239","09939","688658","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815443","title":"创胜集团医药-B(06628)建议委任徐汉森为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815443","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640815443?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:21","pubTimestamp":1780572110,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创胜集团医药-B 发布公告,徐汉森博士(徐博士)将获委任为非执行董事;及包骏博士(包博士)将获委任为独立非执行董事,惟均须待本公司股东于将于2026年6月30日召开的股东周年大会上批准后,方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","BK1515","06628","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153649","title":"差异化创新破局,科望医药领航免疫治疗新蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153649","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153649?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:41","pubTimestamp":1780562506,"startTime":"0","endTime":"0","summary":"当行业竞相追逐成熟靶点时,科望医药选择了更具挑战的源头创新之路,瞄准下一代免疫疗法,成为全球MCE赛道为数不多的定义者与领跑者。","market":"sg","thumbnail":"https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/d273d-c4393547-47e6-485a-a81d-c0fea64e5b84.jpg?guru_height=855&guru_width=1280&guru_size=118253"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5064974","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["09939","159938","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640587161","title":"楚天科技:将楚天打造成世界医药领军企业之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2640587161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640587161?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:24","pubTimestamp":1780561450,"startTime":"0","endTime":"0","summary":"证券之星消息,楚天科技(300358)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问:公司在多次访谈中提到'十五五'期间向百亿级企业迈进,请问公司十五五的总体目标是什么?有没有具体的量化目标?谢谢。楚天科技回复:您好!总体目标系将楚天打造成世界医药领军企业之一,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400027690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1161","159938","BK1515","BK0061","BK1574","09939","BK0077","BK0028","300358"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640391611","title":"长春高新:公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景","url":"https://stock-news.laohu8.com/highlight/detail?id=2640391611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640391611?lang=zh_cn&edition=full","pubTime":"2026-06-04 11:35","pubTimestamp":1780544129,"startTime":"0","endTime":"0","summary":"证券之星消息,长春高新(000661)06月04日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司管理层90%都是地产行业出身,缺少专业性,这是否也导致了公司研发销售管理效率全行业最低?长春高新回复:您好,相关表述与实际不符。公司管理团队涵盖医药、企管、财务、法务、金融等多元专业背景,各医药子公司经营、研发核心团队汇聚大批深耕生物医药领域的专业人才,适配整体经营管理需求,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400014462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0075","159938","BK1574","000661","159940","BK0028","BK0046","BK1515","BK0188","BK1161","09939","BK0057"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640135180","title":"国产双靶点GLP-1迎新进展,翰森制药减重新药申报获受理|医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2640135180","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640135180?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:57","pubTimestamp":1780538268,"startTime":"0","endTime":"0","summary":"截至6月3日收盘,市场冲高回落,沪深两市成交额3.13万亿元。医药ETF(512120)下跌1.46%,港股通生物科技ETF(159102)下跌3.11%。相关个股方面,金斯瑞生物科技上涨10.54%、信达生物下跌2.54%、百济神州下跌2.13%、药明生物下跌7.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606043760000889.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606043760000889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4144","BK1589","03692","BK1161","159938","BK1191","BK1515","BK1574","BK4590","GLP","09939","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640818021","title":"和誉-B(02256):和誉医药于PAGE会议展示ABSK-011(依帕戈替尼)在HCC患者中的联合建模新框架","url":"https://stock-news.laohu8.com/highlight/detail?id=2640818021","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640818021?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:04","pubTimestamp":1780531491,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和誉-B(02256)发布公告,公司的附属公司上海和誉生物医药科技有限公司(和誉医药)宣布,公司在2026年6月2日至5日于克罗地亚杜布罗夫尼克举行的欧洲群体药理学会议(PAGE会议)上,以壁报形式展示了两项基于模型的药物开发新进展。其中一项报告重点展示了一种创新的联合建模框架,用于预测高选择性FGFR4抑制剂ABSK-011(依帕戈替尼)在晚期FGF19+肝细胞癌(HCC)患者中的无进展生存期(PFS)。此外,和誉医药与外部合作方共同展示了一项基于国内自主研发的创新建模软件Maspectra完成的ABSK-011群体药代动力学建模研究,其中包括与NONMEM的比较分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BPRC5H50.USD","LU2476274308.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","HCC","02256","09939","LU2488822045.USD","BK1515","BK4006","159938","BK1574","LU2476274720.SGD","LU2778985437.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640751906","title":"宏辉果蔬推进业务结构升级,7亿元控股施美药业拓展医药赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2640751906","media":"长三角资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640751906?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:07","pubTimestamp":1780484820,"startTime":"0","endTime":"0","summary":"宏辉果蔬近期围绕治理结构、资产配置和产业布局持续推进调整。在生鲜果蔬行业竞争加剧、成本波动加大的背景下,公司通过控制权变更后的内部改革、低效资产处置及外延并购,推动业务结构由单一生鲜主业向多元化经营延伸。 整体来看,宏辉果蔬过去一年围绕控制权、资产结构、财务质量和产业布局完成多项调整。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/csjzbj/2026-06-03/doc-iniactak2317148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK0238","159938","603336","BK1161","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640084779","title":"星昊医药(920017)披露2025年年度权益分派实施公告,6月3日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640084779","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640084779?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:45","pubTimestamp":1780479900,"startTime":"0","endTime":"0","summary":"截至2026年6月3日收盘,星昊医药报收于16.21元,较前一交易日下跌0.06%,最新总市值为20.24亿元。近日,星昊医药发布《2025年年度权益分派实施公告》。公告显示,公司2025年年度权益分派方案已获股东会审议通过,以股权登记日应分配股数123,892,517股为基数,每10股派6.000000元人民币现金,共计派发现金红利74,335,510.20元。本次权益分派不涉及送红股或转增股本。股权登记日为2026年6月10日,除权除息日为2026年6月11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159938","BK1574","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640490824","title":"欧康医药(920230)披露回购股份注销完成暨股份变动公告,6月3日股价下跌0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640490824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640490824?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:44","pubTimestamp":1780479888,"startTime":"0","endTime":"0","summary":"截至2026年6月3日收盘,欧康医药报收于10.6元,较前一交易日下跌0.93%,最新总市值为10.65亿元。近日,欧康医药发布《回购股份注销完成暨股份变动公告》。公告显示,公司通过股份回购专用证券账户回购242,892股,占回购前总股本的0.24%。公司已于2026年6月1日完成上述股份的注销手续。注销完成后,公司股份总额由100,717,495股变更为100,474,603股,剩余库存股为0股。股权结构方面,有限售条件股份由53,469,747股减少至53,226,855股,无限售条件股份比例由46.91%上升至47.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300036467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","09939","BK1515","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781090265814,"stockEarnings":[{"period":"1week","weight":-0.0458},{"period":"1month","weight":-0.1205},{"period":"3month","weight":-0.1287},{"period":"6month","weight":-0.1549},{"period":"1year","weight":-0.138},{"period":"ytd","weight":-0.1341}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0407},{"period":"3month","weight":-0.0299},{"period":"6month","weight":0.0353},{"period":"1year","weight":0.1795},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药,159938,医药股票,医药股票老虎,医药股票老虎国际,医药行情,医药股票行情,医药股价,医药股市,医药股票价格,医药股票交易,医药股票购买,医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}